NCT06939036
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06939036
Title Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 ) (SANTANA-225)
Acronym SANTANA-225
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ariceum Therapeutics GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Biogenix Molecular Miami Florida 33165 United States Details
University of Louisville Health-Brown Cancer Center Louisville Kentucky 40202 United States Details
United Theranostics Glen Burnie Maryland 21061 United States Details
John Theurer Cancer Center at Hackensack UMC Hackensack New Jersey 07601 United States Details
UPMC Pittsburgh Pennsylvania 15219 United States Details
Virginia Cancer Specialists, PC Fairfax Virginia 22031 United States Details
GenesisCare Alexandria Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field